Literature DB >> 17188059

Self-retaining 27-gauge transconjunctival chandelier endoillumination for panoramic viewing during vitreous surgery.

Yusuke Oshima1, Carl C Awh, Yasuo Tano.   

Abstract

PURPOSE: To report the development of a 27-gauge self-retaining transconjunctival chandelier endoilluminator for panoramic viewing during vitrectomy.
DESIGN: New surgical instrument.
METHODS: The tip of the illuminating fiber is 27-gauge (0.35 mm) and shaped like a cone to provide wide-angle illumination. The tip, inserted approximately 3 mm into the vitreous cavity transconjunctivally, provides diffuse illumination. The optical fiber covered by a malleable sleeve can be retained in the eyeball without a suture.
RESULTS: The slim light fiber design (0.35 mm) stabilizes the 27-gauge tip in the eye and provides up to 25 lumens of measured illumination. The adequate lighting potential and self-retaining design allow wide-angle visualization and bimanual manipulation in challenging cases. Easy insertion and removal without suture placement make it convenient to change the position of the device during surgery and efficiently shorten surgical time.
CONCLUSIONS: This suture-free 27-gauge endoillumination chandelier improves the efficacy and efficiency of vitreous surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17188059     DOI: 10.1016/j.ajo.2006.07.051

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Advantages of using newly developed quartz contact lens with slit illumination from operating microscope.

Authors:  Masatoshi Kiyokawa; Toshiro Sakuma; Noriko Hatano; Atsushi Mizota; Minoru Tanaka
Journal:  Int Ophthalmol       Date:  2007-12-20       Impact factor: 2.031

2.  An extraocular non-invasive transscleral LED-endoilluminator for eye speculum integration.

Authors:  Philipp Simon Kölbl; Christoph Lindner; Christian Lingenfelder; Svenja Deuchler; Pankaj Singh; Frank Koch; Martin Hessling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-10       Impact factor: 3.117

3.  Scleral depressed vitreous shaving, 360 laser, and perfluoropropane (C3 F8) for retinal detachment.

Authors:  Vivek Chaturvedi; Ryan P Basham; Kourous A Rezaei
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

4.  Heads-Up Macular Surgery with a 27-Gauge Microincision Vitrectomy System and Minimal Illumination.

Authors:  Hiroshi Kunikata; Toshiaki Abe; Toru Nakazawa
Journal:  Case Rep Ophthalmol       Date:  2016-11-29

5.  Influences of 27-Gauge Vitrectomy on Corneal Topographic Conditions.

Authors:  Takafumi Hirashima; Takao Utsumi; Miou Hirose; Hideyasu Oh
Journal:  J Ophthalmol       Date:  2017-08-27       Impact factor: 1.909

Review 6.  Review of Small Gauge Vitrectomy: Progress and Innovations.

Authors:  Shaheeda Mohamed; Carl Claes; Chi Wai Tsang
Journal:  J Ophthalmol       Date:  2017-05-10       Impact factor: 1.909

7.  Outcomes of transconjunctival sutureless 27-gauge micro-incision vitrectomy surgery in diabetic vitreous haemorrhage.

Authors:  Bashiran Shahzadi; Syed Fawad Rizwi; Faisal Murtaza Qureshi; Kanwal Latif; Syed Asaad Mahmood
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

8.  Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy.

Authors:  Hasenin Al-Khersan; Michael J Venincasa; Amy Kloosterboer; Jayanth Sridhar; William E Smiddy; Justin H Townsend; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2020-06-10

9.  EFFECT OF LUBRICANTS ON CORNEAL THICKNESS AFTER VITRECTOMY.

Authors:  Diane T Siegel; G Baker Hubbard; Jiong Yan; Blaine Cribbs; Nieraj Jain; Steve Yeh; Diem Bui; Jesse Smith; Scott Barb; William Pearce; Laura Ward; Andrew M Hendrick
Journal:  Retina       Date:  2020-08       Impact factor: 3.975

10.  Intraoperative Optical Coherence Tomography-Assisted 27-Gauge Vitrectomy in Eyes with Vitreoretinal Diseases.

Authors:  Hiroshi Kunikata; Toru Nakazawa
Journal:  Case Rep Ophthalmol       Date:  2015-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.